William Blair Investment Management, LLC Dexcom Inc Transaction History

William Blair Investment Management, LLC

$39 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $16,640 - $19,667	-160 Reduced 1.92%	8,155 $947,000
Q4 2022 Feb 09, 2023	SELL	$84.98 - $122.67 $2.69 Million - $3.88 Million	-31,670 Reduced 79.2%	8,315 $941,000
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $315,707 - $389,434	-4,135 Reduced 9.37%	39,985 $3.22 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $2.25 Million - $4.4 Million	33,115 Added 300.91%	44,120 $3.29 Million
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $1.04 Million - $1.43 Million	11,005 New	11,005 $5.63 Million
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $16.5 Million - $20.4 Million	-465,628 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$27.84 - $38.92 $13.2 Million - $18.4 Million	-474,029 Reduced 50.45%	465,628 $69.8 Million
Q1 2019 May 10, 2019	SELL	$28.07 - $38.18 $8.87 Million - $12.1 Million	-315,965 Reduced 25.16%	939,657 $112 Million
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $19.8 Million - $27.5 Million	-734,641 Reduced 36.91%	1,255,622 $150 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $456,445 - $717,802	-19,548 Reduced 0.97%	1,990,263 $285 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $2.65 Million - $3.8 Million	150,845 Added 8.11%	2,009,811 $191 Million
Q1 2018 May 14, 2018	BUY	$13.06 - $18.54 $1.26 Million - $1.79 Million	96,347 Added 5.47%	1,858,966 $138 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $3.83 Million - $5.3 Million	344,294 Added 24.27%	1,762,619 $101 Million
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $16.1 Million - $26.9 Million	1,418,325	1,418,325 $69.4 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.

Account